Powder supplements require minimal oversight beyond initial consultation, while injectable therapy needs ongoing medical monitoring and proper administration techniques
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
Type 2 Diabetes: Semaglutide is used to control high blood sugar levels in adults
Incidentally, sulfide would be restituted upon persulfide reduction by a dithiol reductant
Ideal candidates understand that oral semaglutide is not a cosmetic or temporary solution but a tool for managing a chronic metabolic condition